Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.

Baltzer P, Mann RM, Iima M, Sigmund EE, Clauser P, Gilbert FJ, Martincich L, Partridge SC, Patterson A, Pinker K, Thibault F, Camps-Herrero J, Le Bihan D, EUSOBI international Breast Diffusion-Weighted Imaging working group. · 2020

Read Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. by Baltzer P, Mann RM, Iima M, Sigmund EE, Clauser P, Gilbert FJ, Martincich L, Partridge SC, Patterson A, Pinker K, Thibault F, Camps-Herrero J, Le Bihan D, EUSOBI international Breast Diffusion-Weighted Imaging working group. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7033067.txt.

Introduction

Baltzer and co-authors present a consensus and mission statement in European Radiology. They write for the EUSOBI International Breast Diffusion-Weighted Imaging working group. Diffusion-weighted imaging, or DWI, is an MRI method that can help tell benign breast lesions from cancers. Practice varies widely, though, and results are hard to compare.

The group gives its first shared recommendations. They cover scan settings such as b values, fat saturation, and image resolution. They define levels of diffusion restriction in breast lesions from published data. They also advise how to measure the ADC value in a small, well-chosen region. The group stresses standard methods and quality checks. It aims to move breast DWI into routine clinical use at many sites.

Catalog record

CREATORBaltzer P, Mann RM, Iima M, Sigmund EE, Clauser P, Gilbert FJ, Martincich L, Partridge SC, Patterson A, Pinker K, Thibault F, Camps-Herrero J, Le Bihan D, EUSOBI international Breast Diffusion-Weighted Imaging working group.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7033067

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group By Pascal Baltzer, Ritse M Mann, Mami Iima, Eric E Sigmund, Paola Clauser, Fiona J Gilbert, Laura Martincich, Savannah C Partridge, Andrew Patterson, Katja Pinker, Fabienne Thibault, Julia Camps-Herrero Published in: European Radiology DOI: 10.1007/s00330-019-06510-3 ABSTRACT Abstract The European Society of Breast Radiology (EUSOBI) established an International Breast DWI working group. The working group consists of clinical breast MRI experts, MRI physicists, and representatives from large vendors of MRI equipment, invited based upon proven expertise in breast MRI and/or in particular breast DWI, representing 25 sites from 16 countries. The aims of the working group are (a) to promote the use of breast DWI into clinical practice by issuing consensus statements and initiate collaborative research where appropriate; (b) to define necessary standards and provide practical guidance for clinical application of breast DWI; (c) to develop a standardized and translatable multisite multivendor quality assurance protocol, especially for multisite research studies; (d) to find consensus on optimal methods for image processing/analysis, visualization, and interpretation; and (e) to work collaboratively with system vendors to improve breast DWI sequences. First consensus recommendations, presented in this paper, include acquisition parameters for standard breast DWI sequences including specifications of b values, fat saturation, spatial resolution, and repetition and echo times. To describe lesions in an objective way, levels of diffusion restriction/hindrance in the breast have been defined based on the published literature on breast DWI. The use of a small ROI placed on the darkest part of the lesion on the ADC map, avoiding necrotic, noisy or non-enhancing lesion voxels is currently recommended. The working group emphasizes the need for standardization and quality assurance before ADC thresholds are applied. The working group encourages further research in advanced diffusion techniques and tailored DWI strategies for specific indications. Key Points • The working group considers breast DWI an essential part of a multiparametric breast MRI protocol and encourages its use. • Basic requirements for routine clinical application of breast DWI are provided, including recommendations on b values, fat saturation, spatial resolution, and other sequence parameters. • Diffusion levels in breast lesions are defined based on meta-analysis data and methods to obtain a reliable ADC value are detailed. Electronic supplementary material The online version of this article (10.1007/s00330-019-06510-3) contains supplementary material, which is available to authorized users. Keywords: Diffusion magnetic resonance imaging, Biomarkers, Breast, Breast neoplasms, Consensus INTRODUCTION Diffusion-weighted imaging (DWI) is emerging as a key imaging technique to complement dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the breast. DWI can be used to distinguish between benign and malignant breast lesions [1–13], stratify in situ from invasive disease [14–18], and potentially predict the response to and monitor the effect of neoadjuvant treatment over time [19–25]. Excellent reviews can be found in the literature; however, there is still no clear consensus within the literature on where and how breast DWI should be applied. A major strength of DWI is that the apparent diffusion coefficient (ADC) can be derived from it, providing a quantitative measure of observed diffusion restriction. We use the term “restriction” because it is widely used in the breast DWI literature. However, the term refers specifically to water diffusion in enclosed spaces, whereas ADC is sensitive to multiple processes occurring in human tissue (genuine restricted intracellular motion, compartmental exchange due to cell membrane permeability, hindered extracellular motion, water bounding to macromolecules, blood microcirculation, etc.) [26]. Thus, the term “hindrance” is also used in literature to describe diffusion effects and might be a more accurate description. Advanced protocols and analyses (as discussed later in this statement) may be used to (partly) disambiguate these effects. However, the focus of this statement is on increasing the translation and standardization of DWI for breast cancer evaluation using the established ADC quantification. A current challenge is the large variability in results, i.e., specificity, sensitivity and thresholds, reported for ADC in distinguishing between benign and malignant breast lesions [9]. A less evident challenge is the inconsistent image quality due to different MRI system capabilities as well as equipment and imaging sequences/protocols contributing to a perceived limited usefulness of DWI in clinical practice. These challenges, coupled with the lack of prospectively validated thresholds for supporting diagnostic decisions, have prevented DWI from becoming an established measure that can be easily incorporated into the Breast Imaging Reporting and Data System (BI-RADS, [27]). Nevertheless, DWI has been incorporated (albeit in a qualitative way) into the Prostate Imaging Reporting and Data System (PI-RADS) [28]. In spite of the diversity in DWI protocols (e.g., the lack of standardization and the presence of artifacts), ADC estimation and interpretation methods across clinical sites [9, 29], and composition of breast lesions in the studies [21, 30–33], there is common agreement that DWI is sensitive to tissue microstructure and cellularity and provides quantitative information that can be used for lesion characterization. The improved lesion characterization can reduce the number of unnecessary biopsy recommendations [6, 7, 34, 35], which has been further validated in a multicenter trial [13]. The quantitative nature of ADC measures combined with relatively short acquisition times, typically in the order of 2–4 min but not exceeding 5 min, makes it an ideal imaging biomarker candidate [36]. Consequently, there is great interest to improve the generalizability and reproducibility of breast DWI across institutions and imaging platforms. Moreover, although technically challenging, DWI protocol standardization between different systems and vendors has been achieved in the breast and other organs [21, 24, 37–39]. The International Breast DWI Working Group To address the above-described issues and support standardized implementation of DWI, promote its clinical use, and facilitate its adoption as an integral part of breast MRI interpretation within BI-RADS, an International Breast DWI Working Group was established by the European Society of Breast Radiology (EUSOBI). Members of the working group were invited based upon proven expertise in breast MRI and/or breast DWI, representing 25 sites from 16 countries. Within the working group, a scientific committee was appointed. The full composition of the working group is given in Appendix 1. The primary goals of the International Breast DWI working group are: - To promote the integration of DWI into clinical practice by issuing consensus statements and initiate collaborative research where appropriate - To define standards and provide practical guidance for clinical application of DWI - To develop a standardized and translatable multisite multivendor quality assurance protocol, especially for multisite research studies - To find consensus on optimal methods for image processing/analysis, visualization, and interpretation - To work collaboratively with system vendors to improve breast DWI sequences Members of the working group were first invited to provide information on their protocols with details of acquisition and processing parameters. This revealed substantial heterogeneity of applied DWI protocols, even among experts. The members of the Scientific Committee were then surveyed with a list of points on basic requirements, acquisition parameters, hardware, quality control, analysis and reporting to define the minimum standards for breast DWI, along with technical recommendations to meet these standards. In this statement, we report the requirements for breast DWI that obtained general consensual agreement. The items that reached more than 80% consensus are shown in the Supplementary Material. This

Read the complete text